An open-label trial of the immunogenicity and safety of Prevenar (pneumococcal 7-valent conjugate vaccine [diphteria CRM197 protein conjugate] [Pneumococcal 7-valent CRM197 vaccine conjugate] in healthy infants at 2,4 and 6 months of age
Phase of Trial: Phase IV
Latest Information Update: 25 May 2007
At a glance
- Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Sponsors Wyeth
- 25 May 2007 Status changed from in progress to completed.
- 31 Oct 2006 New trial record.